HCR.20.086 – EESAT2
In EESAT2, we will use advanced biochemical as well as novel ICT technologies to produce new and novel-to-nature antimicrobial peptides with little/no resistance development. Advanced synthetic biological and chemical techniques will be used to further optimize lead antimicrobials.
Keywords
AMR antimicrobials
Submitter
Organisation | Leiden University (LEI) |
Name | Prof. dr. N.I. (Nathaniel) Martin |
n.i.martin@biology.leidenuniv.nl |